Skip to main content
JAMA Network logoLink to JAMA Network
. 2019 Dec 12;5(12):1811. doi: 10.1001/jamaoncol.2019.5667

Error in Figure 2D

PMCID: PMC6990964  PMID: 31830217

In the Original Investigation titled “Circulating Tumor DNA Analyses as Markers of Recurrence Risk and Benefit of Adjuvant Therapy for Stage III Colon Cancer,”1 published online October 17, 2019, a correction was made to Figure 2D to fix the label “Negative-positive,” which had been written as “Positive-negative.” This article was corrected online.

Reference

  • 1.Tie J, Cohen JD, Wang Y, et al. Circulating tumor DNA analyses as markers of recurrence risk and benefit of adjuvant therapy for stage III colon cancer [published online October 17, 2019]. JAMA Oncol. doi: 10.1001/jamaoncol.2019.3616 [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from JAMA Oncology are provided here courtesy of American Medical Association

RESOURCES